Outcomes of Carotid Body Tumor Management with Active Surveillance.

Authors :: Lyle DA
Lopez A
Osofsky R
Wiemann B
Boyd N
Olson G
Rana MA
Source :: The Annals of otology, rhinology, and laryngology [Ann Otol Rhinol Laryngol] 2023 May; Vol. 132 (5), pp. 551-557. Date of Electronic Publication: 2022 Jun 20.
Publication Year :: 2023
Abstract: Objectives: To assess outcomes of carotid body tumors (CBTs) managed with active surveillance.<br />Methods: Retrospective chart review of CBTs managed with active surveillance from 2001 to 2019.<br />Results: A total of 115 cases were identified during chart review. Sixty-five of these patients were managed with active surveillance, and 11 patients had bilateral tumors for a total of 76 tumors. Follow-up records with symptomatic outcomes were available for 51 patients, and 47 tumors had follow-up imaging. Thirty-one (66%) actively surveilled CBTs remained stable or decreased in size while 16 (34%) increased in size. Patients undergoing active surveillance developed symptoms in 12 cases, 6 of these patients underwent surgical intervention. Nine CBTs managed with active surveillance (18%) were ultimately resected. The majority of patients who did not undergo surgical intervention never developed symptoms (36/42, 86%).<br />Conclusions: Active surveillance may be a reasonable approach for a subset of CBTs.